These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9950291)
21. Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: two randomized, open-label, crossover studies in healthy adult volunteers. Kapil R; Nolting A; Roy P; Fiske W; Benedek I; Abramowitz W Clin Ther; 2004 Dec; 26(12):2015-25. PubMed ID: 15823765 [TBL] [Abstract][Full Text] [Related]
22. Bioequivalence evaluation of sparse sampling pharmacokinetics data using bootstrap resampling method. Shen M; Machado SG J Biopharm Stat; 2017; 27(2):257-264. PubMed ID: 27906608 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of area under the concentration curve adjusted by the terminal-phase as a metric to reduce the impact of variability in bioequivalence testing. Lucas AJ; Ogungbenro K; Yang S; Aarons L; Chen C Br J Clin Pharmacol; 2022 Feb; 88(2):619-627. PubMed ID: 34272747 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations. Zhou Q; Ruan ZR; Yuan H; Jiang B; Xu DH World J Gastroenterol; 2006 May; 12(17):2742-8. PubMed ID: 16718762 [TBL] [Abstract][Full Text] [Related]
25. Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs. Hammami MM; Yusuf A; Shire FS; Hussein R; Al-Swayeh R J Negat Results Biomed; 2017 May; 16(1):10. PubMed ID: 28535819 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of a limited sampling method used to determine the bioequivalence of highly variable drugs with long half-lives. Jackson AJ Biopharm Drug Dispos; 2001 Jul; 22(5):179-90. PubMed ID: 11745920 [TBL] [Abstract][Full Text] [Related]
27. Truncated AUC evaluates effectively the bioequivalence of drugs with long half-lives. Endrenyi L; Tothfalusi L Int J Clin Pharmacol Ther; 1997 Apr; 35(4):142-50. PubMed ID: 9112134 [TBL] [Abstract][Full Text] [Related]
28. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
29. Bioequivalence of a prednisolone tablet administered as a single oral dose in healthy male volunteers. Lee HJ; Yoo JY; Kim YG; Han SB; Lee KR Int J Clin Pharmacol Ther; 2004 Sep; 42(9):519-25. PubMed ID: 15487811 [TBL] [Abstract][Full Text] [Related]
30. Bioequivalence study of two azithromycin formulations in healthy subjects. Setiawati E; Deniati SH; Yunaidi DA; Handayani LR; Harinanto G; Santoso ID; Sari AP; Rimainar A Arzneimittelforschung; 2009; 59(9):471-5. PubMed ID: 19856795 [TBL] [Abstract][Full Text] [Related]
31. A replicate study design for testing bioequivalence: a case study on two desmopressin nasal spray preparations. Joukhadar C; Schenk B; Kaehler ST; Kollenz CJ; Bauer P; Müller M; Eichler HG Eur J Clin Pharmacol; 2003 Nov; 59(8-9):631-6. PubMed ID: 14564429 [TBL] [Abstract][Full Text] [Related]
32. Large Intra-subject Variability in Caffeine Pharmacokinetics: Randomized Cross-over Study of Single Caffeine Product. Hammami MM; Alvi SN Drug Res (Stuttg); 2017 Sep; 67(9):539-546. PubMed ID: 28561231 [No Abstract] [Full Text] [Related]
33. The duration of measuring partial AUCs for the assessment of bioequivalence. Endrenyi L; Csizmadia F; Tothfalusi L; Balch AH; Chen ML Pharm Res; 1998 Mar; 15(3):399-404. PubMed ID: 9563068 [TBL] [Abstract][Full Text] [Related]
34. Exposure measures applied to the bioequivalence of two sustained release formulations of bupropion. Midha KK; Rawson MJ; McKay G; Hubbard JW Int J Clin Pharmacol Ther; 2005 May; 43(5):244-54. PubMed ID: 15906590 [TBL] [Abstract][Full Text] [Related]
35. Effect of Truncating AUC at 12, 24 and 48 hr When Evaluating the Bioequivalence of Drugs with a Long Half-Life. Moreno I; Ochoa D; Román M; Cabaleiro T; Abad-Santos F Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):53-7. PubMed ID: 26086613 [TBL] [Abstract][Full Text] [Related]
36. Bioequivalence study of two capsule formulations of omeprazole in healthy volunteers. Allegrini A; Nuzzo L; Scaringi AT; Felaco S; Pavone D; Toniato E; Mezzetti A; Martinotti S; Lenotti G Arzneimittelforschung; 2008; 58(8):385-8. PubMed ID: 18807578 [TBL] [Abstract][Full Text] [Related]
37. Impact of truncated area under the curve on failed bioequivalence studies: a computer simulation analysis. Mahmood I Drug Metabol Drug Interact; 2004; 20(1-2):77-83. PubMed ID: 15283304 [TBL] [Abstract][Full Text] [Related]
38. Bioequivalence study of two clopidogrel film-coated tablet formulations in healthy volunteers. Setiawati E; Yunaidi DA; Handayani LR; Santoso ID; Setiawati A; Tjandrawinata RR Arzneimittelforschung; 2011; 61(12):681-4. PubMed ID: 22282954 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects. Kirjavainen M; Mattila L; Vahteristo M; Korhonen J; Lähelmä S J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):290-297. PubMed ID: 29493402 [TBL] [Abstract][Full Text] [Related]
40. Bioequivalence study of two minocycline capsule formulations in healthy volunteers. Setiawati E; Purnomo A; Deniati SH; Yunaidi DA; Handayani LR; Harinato G; Santoso ID Arzneimittelforschung; 2009; 59(10):532-6. PubMed ID: 19998582 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]